Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway
Yi-Lin Zhang,Fen Liu,Zhi-Bang Li,Xiao-Tao He,Xuan Li,Rui-Xin Wu,Hai-Hua Sun,Shao-Hua Ge,Fa-Ming Chen,Ying An
DOI: https://doi.org/10.1186/s13287-022-02992-z
2022-07-16
Abstract:High glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells (PDLSCs) has long been a challenge to periodontal regeneration for diabetic individuals. Metformin is an anti-hyperglycemic drug that exhibits abundant biological activities associated with cell metabolism and downstream tissue regeneration. However, how metformin combats damage to PDLSC osteogenic differentiation under high glucose and the underlying mechanisms remain unknown.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?